These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 20132001)

  • 21. Recent advances in cancer stem cells.
    Cho RW; Clarke MF
    Curr Opin Genet Dev; 2008 Feb; 18(1):48-53. PubMed ID: 18356041
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of chemotherapy in pediatric nonrhabdomyosarcoma soft-tissue sarcomas.
    Ferrari A
    Expert Rev Anticancer Ther; 2008 Jun; 8(6):929-38. PubMed ID: 18533802
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduced expression of INK4a/ARF genes in stem-like sphere cells from rat sarcomas.
    Fujii H; Honoki K; Tsujiuchi T; Kido A; Yoshitani K; Mori T; Takakura Y
    Biochem Biophys Res Commun; 2007 Oct; 362(3):773-8. PubMed ID: 17761140
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Leukemic stem cells: from metabolic pathways and signaling to a new concept of drug resistance targeting.
    Styczynski J; Drewa T
    Acta Biochim Pol; 2007; 54(4):717-26. PubMed ID: 18080019
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Self-renewal and solid tumor stem cells.
    Al-Hajj M; Clarke MF
    Oncogene; 2004 Sep; 23(43):7274-82. PubMed ID: 15378087
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Addition of granulocyte-colony stimulating factor (G-CSF) to adjuvant treatment may increase survival in patients with operable breast cancer: interaction of G-CSF with dormant micrometastatic breast cancer cells.
    Altundag K; Altundag O; Elkiran ET; Cengiz M; Ozisik Y
    Med Hypotheses; 2004; 63(1):56-8. PubMed ID: 15193347
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multidrug drug resistance in pediatric sarcomas.
    Chan HS; DeBoer G; Haddad G; Ling V
    Hematol Oncol Clin North Am; 1995 Aug; 9(4):889-908. PubMed ID: 7490247
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cancer stem cells in breast cancer and metastasis.
    Lawson JC; Blatch GL; Edkins AL
    Breast Cancer Res Treat; 2009 Nov; 118(2):241-54. PubMed ID: 19731012
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Side population and cancer stem cells: therapeutic implications.
    Moserle L; Ghisi M; Amadori A; Indraccolo S
    Cancer Lett; 2010 Feb; 288(1):1-9. PubMed ID: 19523754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endometrial cancer stem cells: a new target for cancer therapy.
    Kato K
    Anticancer Res; 2012 Jun; 32(6):2283-93. PubMed ID: 22641664
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Senescence bypass in mesenchymal stem cells: a potential pathogenesis and implications of pro-senescence therapy in sarcomas.
    Honoki K; Tsujiuchi T
    Expert Rev Anticancer Ther; 2013 Aug; 13(8):983-96. PubMed ID: 23984899
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cancer stem cells and differentiation therapy.
    Jin X; Jin X; Kim H
    Tumour Biol; 2017 Oct; 39(10):1010428317729933. PubMed ID: 29072131
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ErbB receptors as prognostic and therapeutic drug targets in bone and soft tissue sarcomas.
    Wang H; Yang Q; Fu Z; Zuo D; Hua Y; Cai Z
    Cancer Invest; 2014 Dec; 32(10):533-42. PubMed ID: 25347730
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cancer stem cells: a new paradigm for understanding tumor growth and progression and drug resistance.
    Gangemi R; Paleari L; Orengo AM; Cesario A; Chessa L; Ferrini S; Russo P
    Curr Med Chem; 2009; 16(14):1688-703. PubMed ID: 19442140
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sarcomas as a mise en abyme of mesenchymal stem cells: exploiting interrelationships for cell mediated anticancer therapy.
    Burns JS; Safwat A; Grisendi G; Kassem M; Dominici M
    Cancer Lett; 2012 Dec; 325(1):1-10. PubMed ID: 22659735
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cellular plasticity and drug resistance in sarcoma.
    Lin Z; Fan Z; Zhang X; Wan J; Liu T
    Life Sci; 2020 Dec; 263():118589. PubMed ID: 33069737
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cancer stem cells: Implications for cancer causation and therapy resistance.
    Dean M
    Discov Med; 2005 Jun; 5(27):278-82. PubMed ID: 20704888
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting sarcomas: therapeutic targets and their rational.
    Ordóñez JL; Martins AS; Osuna D; Madoz-Gúrpide J; de Alava E
    Semin Diagn Pathol; 2008 Nov; 25(4):304-16. PubMed ID: 19013896
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cancer stem cells depend on their own niche].
    Kano Y; Ishii H; Konno M; Ohta K; Nishikawa S; Fukusumi T; Hamabe A; Hasegawa S; Ogawa H; Ozaki M; Noguchi Y; Sakai D; Haraguchi N; Kudo T; Satoh T; Doki Y; Mori M
    Gan To Kagaku Ryoho; 2013 Apr; 40(4):419-23. PubMed ID: 23848007
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cancer Stem Cells in Soft-Tissue Sarcomas.
    Martínez-Delgado P; Lacerenza S; Obrador-Hevia A; Lopez-Alvarez M; Mondaza-Hernandez JL; Blanco-Alcaina E; Sanchez-Bustos P; Hindi N; Moura DS; Martin-Broto J
    Cells; 2020 Jun; 9(6):. PubMed ID: 32532153
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.